Tweet
Dear colleagues,
The Second International RSA Meeting will be held April 6-8 2011 at the historic heart of Leiden University,
the oldest university in The Netherlands.
We are extremely happy with the large number of high quality abstracts that we received. We actually had to extend the programme of the meeting to two full days in order to accommodate a reasonable percentage of them. This extension also allowed us to have two additional keynote speakers in the programme. This brings the list of keynote lecturers to: Prof. Johan Kärrholm, Prof. Leif Ryd, Dr. Michael Dunbar, Dr. Richie Gill, and Dr. Maiken Stilling.
The programme promises to give the attendees a broad overview of RSA. We will have several long-term follow-up studies showing the predictive value of RSA for future loosening. There will be a number basic studies showing the potential of RSA when used in new fields such as high speed dynamic analyses. But we also have a vast number of papers focussing on early clinical trials of new prosthesis designs. In addition, there is enough room in the programme to network and socialise with your colleagues and partners.
More information can be found on www.rsaresearch.org
We look forward to welcoming you in Leiden.
Best regards,
Edward Valstar,
Bart Kaptein,
Rob Nelissen
On behalf of the RSA Research Group at Leiden University Medical Center.
The Second International RSA Meeting will be held April 6-8 2011 at the historic heart of Leiden University,
the oldest university in The Netherlands.
We are extremely happy with the large number of high quality abstracts that we received. We actually had to extend the programme of the meeting to two full days in order to accommodate a reasonable percentage of them. This extension also allowed us to have two additional keynote speakers in the programme. This brings the list of keynote lecturers to: Prof. Johan Kärrholm, Prof. Leif Ryd, Dr. Michael Dunbar, Dr. Richie Gill, and Dr. Maiken Stilling.
The programme promises to give the attendees a broad overview of RSA. We will have several long-term follow-up studies showing the predictive value of RSA for future loosening. There will be a number basic studies showing the potential of RSA when used in new fields such as high speed dynamic analyses. But we also have a vast number of papers focussing on early clinical trials of new prosthesis designs. In addition, there is enough room in the programme to network and socialise with your colleagues and partners.
More information can be found on www.rsaresearch.org
We look forward to welcoming you in Leiden.
Best regards,
Edward Valstar,
Bart Kaptein,
Rob Nelissen
On behalf of the RSA Research Group at Leiden University Medical Center.